Skip to main content
All lobbying filings

INVARIANT LLC

INVARIANT LLC filed a Q2 report for BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. on July 16, 2025, reporting $70,000 in lobbying income.

Lobbying for BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. · Animal health and veterinary medicine company

All filings by INVARIANT LLC · Everything BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 16, 2025
Income
$70,000
What the client paid this registrant for the period.
Client based in
Georgia

Official filing document

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Advocate on issues related to transboundary animal disease monitoring, control, and prevention, including as it relates to avian influenza in animal agriculture. Educate Members of Congress and the Administration on Boehringer's capabilities to address emerging animal diseases.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem